Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 7, 2024; 30(9): 1257-1260
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1257
Exploring non-curative endoscopic submucosal dissection: Current treatment optimization and future indication expansion
Yi-Nong Zhu, Xiang-Lei Yuan, Wei Liu, Yu-Hang Zhang, Yi Mou, Bing Hu, Lian-Song Ye
Yi-Nong Zhu, Xiang-Lei Yuan, Wei Liu, Yu-Hang Zhang, Yi Mou, Bing Hu, Lian-Song Ye, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Zhu YN and Yuan XL designed the article; Liu W write the manuscript; Zhang YH and Mou Y searched the lecture; Hu B and Ye LS revised the manuscript.
Supported by the China Postdoctoral Science Foundation, No. 2022M712265.
Conflict-of-interest statement: All authors disclosed no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lian-Song Ye, MD, Doctor, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, No. 37 of Guoxue Alley, Chengdu 610041, Sichuan Province, China. yeliansongnj@wchscu.edu.cn
Received: December 18, 2023
Peer-review started: December 18, 2023
First decision: January 15, 2024
Revised: January 17, 2024
Accepted: February 18, 2024
Article in press: February 18, 2024
Published online: March 7, 2024
Processing time: 78 Days and 23.4 Hours
Core Tip

Core Tip: The quality control of endoscopic submucosal dissection (ESD) has gained increasing attention, and concurrently, the management of patients with non-curative ESD outcomes is equally crucial. Existing guidelines offer unclear recommendations for the management of patients classified as endoscopic curability C-1 after the procedure, warranting the need for further clinical research to refine treatment strategies for this patient population.